Table 2.
Go term analysis derived from biological process of human cerebral organoids after OGD/R (FDR < 0.05).
| Term | Count | P-value | FDR |
|---|---|---|---|
| Retinoid metabolic process | 11 | 5.91E-17 | 1.55E-13 |
| Platelet degranulation | 9 | 5.07E-11 | 7.27E-08 |
| Lipoprotein metabolic process | 7 | 1.96E-10 | 2.81E-07 |
| Cholesterol efflux | 6 | 2.02E-09 | 2.89E-06 |
| Lipoprotein biosynthetic process | 5 | 2.49E-09 | 3.58E-06 |
| Phospholipid efflux | 5 | 1.97E-08 | 2.82E-05 |
| High-density lipoprotein particle remodeling | 5 | 2.68E-08 | 3.84E-05 |
| Reverse cholesterol transport | 5 | 5.97E-08 | 8.56E-05 |
| Triglyceride catabolic process | 5 | 2.44E-07 | 3.50E-04 |
| Cholesterol homeostasis | 6 | 2.72E-07 | 3.90E-04 |
| High-density lipoprotein particle assembly | 4 | 5.47E-07 | 7.85E-04 |
| Positive regulation of cholesterol esterification | 4 | 8.20E-07 | 0.001176 |
| Protein polymerization | 4 | 2.77E-06 | 0.003979 |
| Negative regulation of very-low-density lipoprotein particle remodeling | 3 | 1.42E-05 | 0.020297 |
| Cholesterol metabolic process | 5 | 1.47E-05 | 0.021062 |
| Lipid transport | 5 | 2.28E-05 | 0.032765 |
| Triglyceride homeostasis | 4 | 2.47E-05 | 0.035457 |
| Blood coagulation, fibrin clot formation | 3 | 2.83E-05 | 0.040534 |